Gilead pays $45M to settle Texas Medicaid kickback allegations

Gilead Sciences will pay $45 million to resolve Texas Attorney General claims that it paid kickbacks to influence Medicaid prescriptions. The settlement resolves civil allegations without admission of liability. It signals continued state-level scrutiny of pharmaceutical marketing practices and potential financial impact on Gilead.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works